Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172456 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: 99mTc-radiolabelled tiotropium
DRUG: non-radiolabelled tiotropium

Sponsor

Boehringer Ingelheim